Global Enramycin Premix Market Growth 2022-2028
As the global economy mends, the 2021 growth of Enramycin Premix will have significant change from previous year. According to our (LP Information) latest study, the global Enramycin Premix market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Enramycin Premix market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Enramycin Premix market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Enramycin Premix market, reaching US$ million by the year 2028. As for the Europe Enramycin Premix landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Enramycin Premix players cover Takeda, AdvaCare, Phiphar Healthcare, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Enramycin Premix market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Contains Enramycin 4%
Contains Enramycin 8%
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pig Fodder
Chicken Fodder
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Takeda
AdvaCare
Phiphar Healthcare
Boehringer Ingelheim
Eli Lilly and Company
Ravioza Biotech
Zhejiang Dayang Biology Technology
Bornsun Bioengineering
Shandong Shengli Bioengineering
Apeloa Pharmaceutical
Hvsen Biotechnology
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Enramycin Premix Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Enramycin Premix by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Enramycin Premix by Country/Region, 2017, 2022 & 2028
2.2 Enramycin Premix Segment by Type
2.2.1 Contains Enramycin 4%
2.2.2 Contains Enramycin 8%
2.3 Enramycin Premix Sales by Type
2.3.1 Global Enramycin Premix Sales Market Share by Type (2017-2022)
2.3.2 Global Enramycin Premix Revenue and Market Share by Type (2017-2022)
2.3.3 Global Enramycin Premix Sale Price by Type (2017-2022)
2.4 Enramycin Premix Segment by Application
2.4.1 Pig Fodder
2.4.2 Chicken Fodder
2.4.3 Others
2.5 Enramycin Premix Sales by Application
2.5.1 Global Enramycin Premix Sale Market Share by Application (2017-2022)
2.5.2 Global Enramycin Premix Revenue and Market Share by Application (2017-2022)
2.5.3 Global Enramycin Premix Sale Price by Application (2017-2022)
3 Global Enramycin Premix by Company
3.1 Global Enramycin Premix Breakdown Data by Company
3.1.1 Global Enramycin Premix Annual Sales by Company (2020-2022)
3.1.2 Global Enramycin Premix Sales Market Share by Company (2020-2022)
3.2 Global Enramycin Premix Annual Revenue by Company (2020-2022)
3.2.1 Global Enramycin Premix Revenue by Company (2020-2022)
3.2.2 Global Enramycin Premix Revenue Market Share by Company (2020-2022)
3.3 Global Enramycin Premix Sale Price by Company
3.4 Key Manufacturers Enramycin Premix Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Enramycin Premix Product Location Distribution
3.4.2 Players Enramycin Premix Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Enramycin Premix by Geographic Region
4.1 World Historic Enramycin Premix Market Size by Geographic Region (2017-2022)
4.1.1 Global Enramycin Premix Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Enramycin Premix Annual Revenue by Geographic Region
4.2 World Historic Enramycin Premix Market Size by Country/Region (2017-2022)
4.2.1 Global Enramycin Premix Annual Sales by Country/Region (2017-2022)
4.2.2 Global Enramycin Premix Annual Revenue by Country/Region
4.3 Americas Enramycin Premix Sales Growth
4.4 APAC Enramycin Premix Sales Growth
4.5 Europe Enramycin Premix Sales Growth
4.6 Middle East & Africa Enramycin Premix Sales Growth
5 Americas
5.1 Americas Enramycin Premix Sales by Country
5.1.1 Americas Enramycin Premix Sales by Country (2017-2022)
5.1.2 Americas Enramycin Premix Revenue by Country (2017-2022)
5.2 Americas Enramycin Premix Sales by Type
5.3 Americas Enramycin Premix Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Enramycin Premix Sales by Region
6.1.1 APAC Enramycin Premix Sales by Region (2017-2022)
6.1.2 APAC Enramycin Premix Revenue by Region (2017-2022)
6.2 APAC Enramycin Premix Sales by Type
6.3 APAC Enramycin Premix Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Enramycin Premix by Country
7.1.1 Europe Enramycin Premix Sales by Country (2017-2022)
7.1.2 Europe Enramycin Premix Revenue by Country (2017-2022)
7.2 Europe Enramycin Premix Sales by Type
7.3 Europe Enramycin Premix Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Enramycin Premix by Country
8.1.1 Middle East & Africa Enramycin Premix Sales by Country (2017-2022)
8.1.2 Middle East & Africa Enramycin Premix Revenue by Country (2017-2022)
8.2 Middle East & Africa Enramycin Premix Sales by Type
8.3 Middle East & Africa Enramycin Premix Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Enramycin Premix
10.3 Manufacturing Process Analysis of Enramycin Premix
10.4 Industry Chain Structure of Enramycin Premix
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Enramycin Premix Distributors
11.3 Enramycin Premix Customer
12 World Forecast Review for Enramycin Premix by Geographic Region
12.1 Global Enramycin Premix Market Size Forecast by Region
12.1.1 Global Enramycin Premix Forecast by Region (2023-2028)
12.1.2 Global Enramycin Premix Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Enramycin Premix Forecast by Type
12.7 Global Enramycin Premix Forecast by Application
13 Key Players Analysis
13.1 Takeda
13.1.1 Takeda Company Information
13.1.2 Takeda Enramycin Premix Product Offered
13.1.3 Takeda Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Takeda Main Business Overview
13.1.5 Takeda Latest Developments
13.2 AdvaCare
13.2.1 AdvaCare Company Information
13.2.2 AdvaCare Enramycin Premix Product Offered
13.2.3 AdvaCare Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AdvaCare Main Business Overview
13.2.5 AdvaCare Latest Developments
13.3 Phiphar Healthcare
13.3.1 Phiphar Healthcare Company Information
13.3.2 Phiphar Healthcare Enramycin Premix Product Offered
13.3.3 Phiphar Healthcare Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Phiphar Healthcare Main Business Overview
13.3.5 Phiphar Healthcare Latest Developments
13.4 Boehringer Ingelheim
13.4.1 Boehringer Ingelheim Company Information
13.4.2 Boehringer Ingelheim Enramycin Premix Product Offered
13.4.3 Boehringer Ingelheim Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Boehringer Ingelheim Main Business Overview
13.4.5 Boehringer Ingelheim Latest Developments
13.5 Eli Lilly and Company
13.5.1 Eli Lilly and Company Company Information
13.5.2 Eli Lilly and Company Enramycin Premix Product Offered
13.5.3 Eli Lilly and Company Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Eli Lilly and Company Main Business Overview
13.5.5 Eli Lilly and Company Latest Developments
13.6 Ravioza Biotech
13.6.1 Ravioza Biotech Company Information
13.6.2 Ravioza Biotech Enramycin Premix Product Offered
13.6.3 Ravioza Biotech Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Ravioza Biotech Main Business Overview
13.6.5 Ravioza Biotech Latest Developments
13.7 Zhejiang Dayang Biology Technology
13.7.1 Zhejiang Dayang Biology Technology Company Information
13.7.2 Zhejiang Dayang Biology Technology Enramycin Premix Product Offered
13.7.3 Zhejiang Dayang Biology Technology Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Zhejiang Dayang Biology Technology Main Business Overview
13.7.5 Zhejiang Dayang Biology Technology Latest Developments
13.8 Bornsun Bioengineering
13.8.1 Bornsun Bioengineering Company Information
13.8.2 Bornsun Bioengineering Enramycin Premix Product Offered
13.8.3 Bornsun Bioengineering Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bornsun Bioengineering Main Business Overview
13.8.5 Bornsun Bioengineering Latest Developments
13.9 Shandong Shengli Bioengineering
13.9.1 Shandong Shengli Bioengineering Company Information
13.9.2 Shandong Shengli Bioengineering Enramycin Premix Product Offered
13.9.3 Shandong Shengli Bioengineering Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shandong Shengli Bioengineering Main Business Overview
13.9.5 Shandong Shengli Bioengineering Latest Developments
13.10 Apeloa Pharmaceutical
13.10.1 Apeloa Pharmaceutical Company Information
13.10.2 Apeloa Pharmaceutical Enramycin Premix Product Offered
13.10.3 Apeloa Pharmaceutical Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Apeloa Pharmaceutical Main Business Overview
13.10.5 Apeloa Pharmaceutical Latest Developments
13.11 Hvsen Biotechnology
13.11.1 Hvsen Biotechnology Company Information
13.11.2 Hvsen Biotechnology Enramycin Premix Product Offered
13.11.3 Hvsen Biotechnology Enramycin Premix Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hvsen Biotechnology Main Business Overview
13.11.5 Hvsen Biotechnology Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Enramycin Premix Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Enramycin Premix Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Contains Enramycin 4%
Table 4. Major Players of Contains Enramycin 8%
Table 5. Global Enramycin Premix Sales by Type (2017-2022) & (Tons)
Table 6. Global Enramycin Premix Sales Market Share by Type (2017-2022)
Table 7. Global Enramycin Premix Revenue by Type (2017-2022) & ($ million)
Table 8. Global Enramycin Premix Revenue Market Share by Type (2017-2022)
Table 9. Global Enramycin Premix Sale Price by Type (2017-2022) & (US$/Ton)
Table 10. Global Enramycin Premix Sales by Application (2017-2022) & (Tons)
Table 11. Global Enramycin Premix Sales Market Share by Application (2017-2022)
Table 12. Global Enramycin Premix Revenue by Application (2017-2022)
Table 13. Global Enramycin Premix Revenue Market Share by Application (2017-2022)
Table 14. Global Enramycin Premix Sale Price by Application (2017-2022) & (US$/Ton)
Table 15. Global Enramycin Premix Sales by Company (2020-2022) & (Tons)
Table 16. Global Enramycin Premix Sales Market Share by Company (2020-2022)
Table 17. Global Enramycin Premix Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Enramycin Premix Revenue Market Share by Company (2020-2022)
Table 19. Global Enramycin Premix Sale Price by Company (2020-2022) & (US$/Ton)
Table 20. Key Manufacturers Enramycin Premix Producing Area Distribution and Sales Area
Table 21. Players Enramycin Premix Products Offered
Table 22. Enramycin Premix Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Enramycin Premix Sales by Geographic Region (2017-2022) & (Tons)
Table 26. Global Enramycin Premix Sales Market Share Geographic Region (2017-2022)
Table 27. Global Enramycin Premix Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Enramycin Premix Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Enramycin Premix Sales by Country/Region (2017-2022) & (Tons)
Table 30. Global Enramycin Premix Sales Market Share by Country/Region (2017-2022)
Table 31. Global Enramycin Premix Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Enramycin Premix Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Enramycin Premix Sales by Country (2017-2022) & (Tons)
Table 34. Americas Enramycin Premix Sales Market Share by Country (2017-2022)
Table 35. Americas Enramycin Premix Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Enramycin Premix Revenue Market Share by Country (2017-2022)
Table 37. Americas Enramycin Premix Sales by Type (2017-2022) & (Tons)
Table 38. Americas Enramycin Premix Sales Market Share by Type (2017-2022)
Table 39. Americas Enramycin Premix Sales by Application (2017-2022) & (Tons)
Table 40. Americas Enramycin Premix Sales Market Share by Application (2017-2022)
Table 41. APAC Enramycin Premix Sales by Region (2017-2022) & (Tons)
Table 42. APAC Enramycin Premix Sales Market Share by Region (2017-2022)
Table 43. APAC Enramycin Premix Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Enramycin Premix Revenue Market Share by Region (2017-2022)
Table 45. APAC Enramycin Premix Sales by Type (2017-2022) & (Tons)
Table 46. APAC Enramycin Premix Sales Market Share by Type (2017-2022)
Table 47. APAC Enramycin Premix Sales by Application (2017-2022) & (Tons)
Table 48. APAC Enramycin Premix Sales Market Share by Application (2017-2022)
Table 49. Europe Enramycin Premix Sales by Country (2017-2022) & (Tons)
Table 50. Europe Enramycin Premix Sales Market Share by Country (2017-2022)
Table 51. Europe Enramycin Premix Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Enramycin Premix Revenue Market Share by Country (2017-2022)
Table 53. Europe Enramycin Premix Sales by Type (2017-2022) & (Tons)
Table 54. Europe Enramycin Premix Sales Market Share by Type (2017-2022)
Table 55. Europe Enramycin Premix Sales by Application (2017-2022) & (Tons)
Table 56. Europe Enramycin Premix Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Enramycin Premix Sales by Country (2017-2022) & (Tons)
Table 58. Middle East & Africa Enramycin Premix Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Enramycin Premix Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Enramycin Premix Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Enramycin Premix Sales by Type (2017-2022) & (Tons)
Table 62. Middle East & Africa Enramycin Premix Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Enramycin Premix Sales by Application (2017-2022) & (Tons)
Table 64. Middle East & Africa Enramycin Premix Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Enramycin Premix
Table 66. Key Market Challenges & Risks of Enramycin Premix
Table 67. Key Industry Trends of Enramycin Premix
Table 68. Enramycin Premix Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Enramycin Premix Distributors List
Table 71. Enramycin Premix Customer List
Table 72. Global Enramycin Premix Sales Forecast by Region (2023-2028) & (Tons)
Table 73. Global Enramycin Premix Sales Market Forecast by Region
Table 74. Global Enramycin Premix Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Enramycin Premix Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Enramycin Premix Sales Forecast by Country (2023-2028) & (Tons)
Table 77. Americas Enramycin Premix Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Enramycin Premix Sales Forecast by Region (2023-2028) & (Tons)
Table 79. APAC Enramycin Premix Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Enramycin Premix Sales Forecast by Country (2023-2028) & (Tons)
Table 81. Europe Enramycin Premix Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Enramycin Premix Sales Forecast by Country (2023-2028) & (Tons)
Table 83. Middle East & Africa Enramycin Premix Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Enramycin Premix Sales Forecast by Type (2023-2028) & (Tons)
Table 85. Global Enramycin Premix Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Enramycin Premix Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Enramycin Premix Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Enramycin Premix Sales Forecast by Application (2023-2028) & (Tons)
Table 89. Global Enramycin Premix Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Enramycin Premix Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Enramycin Premix Revenue Market Share Forecast by Application (2023-2028)
Table 92. Takeda Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 93. Takeda Enramycin Premix Product Offered
Table 94. Takeda Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 95. Takeda Main Business
Table 96. Takeda Latest Developments
Table 97. AdvaCare Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 98. AdvaCare Enramycin Premix Product Offered
Table 99. AdvaCare Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 100. AdvaCare Main Business
Table 101. AdvaCare Latest Developments
Table 102. Phiphar Healthcare Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 103. Phiphar Healthcare Enramycin Premix Product Offered
Table 104. Phiphar Healthcare Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 105. Phiphar Healthcare Main Business
Table 106. Phiphar Healthcare Latest Developments
Table 107. Boehringer Ingelheim Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 108. Boehringer Ingelheim Enramycin Premix Product Offered
Table 109. Boehringer Ingelheim Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 110. Boehringer Ingelheim Main Business
Table 111. Boehringer Ingelheim Latest Developments
Table 112. Eli Lilly and Company Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 113. Eli Lilly and Company Enramycin Premix Product Offered
Table 114. Eli Lilly and Company Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 115. Eli Lilly and Company Main Business
Table 116. Eli Lilly and Company Latest Developments
Table 117. Ravioza Biotech Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 118. Ravioza Biotech Enramycin Premix Product Offered
Table 119. Ravioza Biotech Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 120. Ravioza Biotech Main Business
Table 121. Ravioza Biotech Latest Developments
Table 122. Zhejiang Dayang Biology Technology Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 123. Zhejiang Dayang Biology Technology Enramycin Premix Product Offered
Table 124. Zhejiang Dayang Biology Technology Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 125. Zhejiang Dayang Biology Technology Main Business
Table 126. Zhejiang Dayang Biology Technology Latest Developments
Table 127. Bornsun Bioengineering Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 128. Bornsun Bioengineering Enramycin Premix Product Offered
Table 129. Bornsun Bioengineering Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 130. Bornsun Bioengineering Main Business
Table 131. Bornsun Bioengineering Latest Developments
Table 132. Shandong Shengli Bioengineering Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 133. Shandong Shengli Bioengineering Enramycin Premix Product Offered
Table 134. Shandong Shengli Bioengineering Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 135. Shandong Shengli Bioengineering Main Business
Table 136. Shandong Shengli Bioengineering Latest Developments
Table 137. Apeloa Pharmaceutical Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 138. Apeloa Pharmaceutical Enramycin Premix Product Offered
Table 139. Apeloa Pharmaceutical Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 140. Apeloa Pharmaceutical Main Business
Table 141. Apeloa Pharmaceutical Latest Developments
Table 142. Hvsen Biotechnology Basic Information, Enramycin Premix Manufacturing Base, Sales Area and Its Competitors
Table 143. Hvsen Biotechnology Enramycin Premix Product Offered
Table 144. Hvsen Biotechnology Enramycin Premix Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 145. Hvsen Biotechnology Main Business
Table 146. Hvsen Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Enramycin Premix
Figure 2. Enramycin Premix Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Enramycin Premix Sales Growth Rate 2017-2028 (Tons)
Figure 7. Global Enramycin Premix Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Enramycin Premix Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Contains Enramycin 4%
Figure 10. Product Picture of Contains Enramycin 8%
Figure 11. Global Enramycin Premix Sales Market Share by Type in 2021
Figure 12. Global Enramycin Premix Revenue Market Share by Type (2017-2022)
Figure 13. Enramycin Premix Consumed in Pig Fodder
Figure 14. Global Enramycin Premix Market: Pig Fodder (2017-2022) & (Tons)
Figure 15. Enramycin Premix Consumed in Chicken Fodder
Figure 16. Global Enramycin Premix Market: Chicken Fodder (2017-2022) & (Tons)
Figure 17. Enramycin Premix Consumed in Others
Figure 18. Global Enramycin Premix Market: Others (2017-2022) & (Tons)
Figure 19. Global Enramycin Premix Sales Market Share by Application (2017-2022)
Figure 20. Global Enramycin Premix Revenue Market Share by Application in 2021
Figure 21. Enramycin Premix Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Enramycin Premix Revenue Market Share by Company in 2021
Figure 23. Global Enramycin Premix Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Enramycin Premix Revenue Market Share by Geographic Region in 2021
Figure 25. Global Enramycin Premix Sales Market Share by Region (2017-2022)
Figure 26. Global Enramycin Premix Revenue Market Share by Country/Region in 2021
Figure 27. Americas Enramycin Premix Sales 2017-2022 (Tons)
Figure 28. Americas Enramycin Premix Revenue 2017-2022 ($ Millions)
Figure 29. APAC Enramycin Premix Sales 2017-2022 (Tons)
Figure 30. APAC Enramycin Premix Revenue 2017-2022 ($ Millions)
Figure 31. Europe Enramycin Premix Sales 2017-2022 (Tons)
Figure 32. Europe Enramycin Premix Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Enramycin Premix Sales 2017-2022 (Tons)
Figure 34. Middle East & Africa Enramycin Premix Revenue 2017-2022 ($ Millions)
Figure 35. Americas Enramycin Premix Sales Market Share by Country in 2021
Figure 36. Americas Enramycin Premix Revenue Market Share by Country in 2021
Figure 37. United States Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Enramycin Premix Sales Market Share by Region in 2021
Figure 42. APAC Enramycin Premix Revenue Market Share by Regions in 2021
Figure 43. China Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Enramycin Premix Sales Market Share by Country in 2021
Figure 50. Europe Enramycin Premix Revenue Market Share by Country in 2021
Figure 51. Germany Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Enramycin Premix Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Enramycin Premix Revenue Market Share by Country in 2021
Figure 58. Egypt Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Enramycin Premix Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Enramycin Premix in 2021
Figure 64. Manufacturing Process Analysis of Enramycin Premix
Figure 65. Industry Chain Structure of Enramycin Premix
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Reason to Buy
- Current and future of Agriculture Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Agriculture Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Agriculture Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Agriculture Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets